Crescent Biopharma Inc (CBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 10,163 | 0 | 0 | 0 | 19 |
| Gross Profit | 10,163 | N/A | N/A | N/A | 19 |
| Operating Expenses | 61,672 | 61,389 | 51,505 | 33,932 | 31,932 |
| Operating Income | -51,509 | -61,389 | -51,505 | -33,932 | -31,914 |
| Other Income | 483 | 3,497 | 3,231 | 651 | 104 |
| Pre-tax Income | -51,027 | -57,892 | -48,274 | -33,281 | -31,810 |
| Net Income Continuous | -51,027 | -57,892 | -48,274 | -33,281 | -31,810 |
| Net Income | $-51,027 | $-57,892 | $-48,274 | $-33,281 | $-31,810 |
| EPS Basic Total Ops | -112.00 | -134.00 | -118.00 | -113.00 | -150.00 |
| EPS Basic Continuous Ops | -111.61 | -133.84 | -117.61 | -113.22 | -149.65 |
| EPS Diluted Total Ops | -112.00 | -134.00 | -118.00 | -113.00 | -150.00 |
| EPS Diluted Continuous Ops | -111.61 | -133.84 | -117.61 | -113.22 | -149.65 |
| EPS Diluted Before Non-Recurring Items | -112.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-51,239 | $-61,110 | $-51,230 | $-33,669 | $-31,723 |